(
340
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paper
-
A systematic review and meta-analysis on absolute eosinophil counts and the risk of asthma in preschool children with wheezing: An EAACI Task Force Report
-
A systematic review and meta-analysis on nutritional and dietary interventions for the treatment of acute respiratory infection in pediatric patients: An EAACI taskforce
-
AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus-A joint EAACI-EANO position paper
-
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper
-
AllergoOncology: Microbiota in allergy and cancer – A European Academy for Allergy and Clinical Immunology position paper
-
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatment
-
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paper
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus
-
EAACI Research and Outreach Committee: Improving standards and facilitating global collaboration through a Research Excellence Network
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
-
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document
-
Eosinophils – from cradle to grave: An EAACI task force paper on new molecular insights and clinical functions of eosinophils and the clinical effects of targeted eosinophil depletion
-
Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest Group
-
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)
-
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives – A report of the European Academy of Allergy and Clinical Immunology (EAACI)
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey
-
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)
-
The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce project
-
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paper
-
A systematic review and meta-analysis of nutritional and dietary interventions in randomized controlled trials for skin symptoms in children with atopic dermatitis and without food allergy: An EAACI task force report
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needs
-
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research – The European Strategic Forum on Allergic Diseases
-
Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies – Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology task force
Show more Position Papers (27)Show Less-
-
2’FL and LNnT shape the gut microbiome and metabolome in CMPA
-
Aeroallergen exposure and climate change: challenges and solutions
-
Allergoids conjugated to mannan reprogram monocytes into tolerogenic dendritic cells through innate memory mechanisms involving epigenetic changes and metabolic reprogramming
-
Basophil activation tests and allergy to COVID-19 vaccines
-
Component Resolved Diagnosis and pollen Immunotherapy indication
-
Contemporary view on mechanisms in allergic and immunologic diseases
-
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
-
Does human milk and its composition matter for development and prevention of allergies?
-
Dupilumab and live-attenuated vaccines: experience with prior dupilumab use and yellow fever vaccine in patients with severe asthma from Brazil
-
Epidemiology and mechanisms of food allergy
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
Flash talks on food allergy and immunotherapy
-
How to select and follow a biological for asthma and CRSwNP
-
Improving patient care with allergen immunotherapy (AIT): Lessons learned from randomised control trials (RCT) and real world evidence (RWE) studies
-
Next generation vaccinology and allergen immunotherapy: from mechanisms to practice
-
Prescribing immunotherapy to pollens in children: influence of geographical and sociological diversity
-
Safety and prediction of allergen immunotherapy
-
Standardisation of Allergen Immunotherapy products and Legal Considerations
-
Vaccines for older adults: benefits and limitations
-
What do clinical trials and real world tell us about allergy and asthma treatment?
-
Why is a transition clinic needed for adolescents and young adults (AYA) with allergy and asthma?
-
Siblings and atopy by living standard, period, and atopy assessment method: a systematic review and meta-analysis
-
Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy
Show more Event Resources (21)Show Less-
-
Aeroallergen immunotherapy before five years of age and elderly
-
Allergen Immunotherapy and Biologicals
-
Development of an easy and automate tool for WG/IG and IS evaluation- “e-VALUATION”
-
Eosinophilic esophagitis and allergen immunotherapy
-
Joint-TF of CVA and One Health “Intersection of Comparative Allergology and One Health”
-
Mechanisms and biomarkers involved in Drug Hypersensitivity Reactions
-
Prevalence and predictive factors for co-morbid CRS and asthma
-
Prevalence and predictive factors for co-morbid CRS and asthma
-
Public outreach for immunological mechanisms in allergies and asthma
-
Urticaria and anaphylaxis in endurance and ultra-endurance athletes: a proposal for pre-race risk assessment
-
Allergen immunotherapy and co-evaluation of COVID-19 vaccines
-
“IgE binding proteins from bacteria, protozoans, helminths and fungi and their impact on precision diagnosis and prevention of allergic diseases”- Acronyme: BACALL
Show more Task Forces (10)Show Less-
-
Angiotensin‐converting enzyme II expression and its implication in the association between COVID‐19 and allergic rhinitis
-
Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE declaration
-
COVID-19 Pandemic and allergen immunotherapy – an EAACI survey
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold – an ARIA- EAACI – GA2LEN consensus
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines
-
SARS-COV-2 Candidate vaccines – composition, mechanisms of action and stages of clinical development 
-
Vaccines and allergic reactions: the past, the current COVID‐19 pandemic, and future perspectives
Show more Covid-19 (5)Show Less-
-
AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus-A joint EAACI-EANO position paper
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall document
Show more Consensus Documents (2)Show Less-
-
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
-
Targeting Type 2 mechanisms in patients with atopic dermatitis and comorbid Type 2 Inflammatory disease: A case-based reflection
-
“Allergen Harmony”: New data for a tailored and sustained food and respiratory immunotherapy effect
Show more Sponsored Symposia (1)Show Less-
-
Food Allergy and Anaphylaxis: Latest updates in the diagnosis and management of food allergy
-
Food Allergy and Anaphylaxis: Needs, perspectives and best practices for patients with food allergy
-
Module 1: The challenges and how we can work with adolescents and young adults
Show more Courses (1)Show Less-
Website
Collapse
-
131 genetic loci highlight immunological pathways and tissues in asthma and nasal polyposis
-
300 IR 5-grass pollen sublingual immunotherapy tablet for allergic rhinoconjunctivitis: A systematic review and meta-analysis of randomised studies
-
A gut microbiome metabolite that heals gut and skin epithelial barrier and shows anti-inflammatory effects
-
ANCHOR-1 and 2 Study Design: Replicate Phase 3 Randomised, Double-Blind, Placebo-Controlled Studies of the Efficacy and Safety of Depemokimab in Patients with Chronic Rhinosinusitis with Nasal Polyps
-
ASSESS FA, the International, Cross-Sectional Prevalence and Severity Study of Paediatric and Adult IgE-mediated Food Allergies – Burden of Food Allergy on Quality of Life Results
-
Adverse Health Outcomes and Patient and Physician Perspectives of Attenuated Androgen Use in Hereditary Angioedema
-
AlbAllergy 5.6 A novel e-platform for Patients and Physicians in Allergy and Immunology
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen Immunotherapy Improves Bronchial Epithelial Tolerance and Antiviral Responses in Patients with House Dust Mite Allergic Asthma
-
Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19
-
Allergen immunotherapy – Basic and clinical perspective
-
Allergen-specific immunotherapy based on purified and modified Fel d 1 allergen from cat dander
-
AllergoOncology: Application of the basophil activation test (BAT) in pre-clinical testing and the first-in-class clinical trial of anti-cancer IgE immunotherapy
-
AllergoOncology: B cell phenotype and immunoglobulin isotype predict immune related adverse events and response to checkpoint inhibitor therapy in advanced melanoma
-
Amlitelimab (an OX40 ligand antibody) significantly reduces serum IgE and LDH, and epidermal hyperplasia in adults with moderate-to-severe atopic dermatitis
-
An allergy educational intervention improved preschool and school personnel knowledge and routines: a mixed methods study
-
An interim analysis of a multi-center, oPEn label, Randomized study to investigate the saFEty of an optimal acCelerated scheme for immunoTherapy in adolescent and adult patients with moderate to severe AR with or without asthma in China. (PERFECT)
-
Analysis of all allergy and hypersensitivity reactions to anti-COVID19 vaccines according to the EUDRA Vigilance database
-
Analysis of all allergy and hypersensitivity reactions to anti-COVID19 vaccines according to the EUDRA Vigilance database
-
Analysis of immunological and cellular tolerance biomarkers during bee venom immunotherapy
-
Anaphylaxis and other severe paediatric allergies in Finland and Sweden between 2012-2020
-
Artificial intelligence and precision immunology: pioneering biomarker discovery in allergen immunotherapy
-
Assessing the impact of nanoplastics on mitochondrial function and glycolytic activity in human bronchial smooth muscles, epithelial cells, and peripheral blood mononuclear cells
-
Assessment of milk and egg ladder in real-world settings: Parental perspectives on challenges and opportunities for enhancement
-
Assessment of symptoms and mucosal specific IgEs presence induced by NPT and natural dust mites exposure in LAR patients
-
Assessment of the state of anxiety and depression of doctors – allergists in Ukraine and the quality of medical care related to it
-
Association between 25-hydroxy vitamin D and pulmonary function among obese and asthma children
-
Association between 25-hydroxy vitamin D and pulmonary function among obese and asthma children
-
Association between ultra-processed food intake and specific IgE-defined food allergies in children and adults from the general U.S. population
-
Asthma Right Care – the growth of the social movement to reduce reliance on episodic care and to increase long term safe and person-centred care
-
At the core of allergy and asthma pathology: exploring the connection between airway epithelium and effector cells
-
Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies
-
Balancing HAE and pregnancy: treatment recommendations and approaches
-
Bumblebee venom allergy as an emerging occupational allergy: safety and efficacy of bumblebee venom immunotherapy in a large single-center cohort
-
Burden and subtypes of early-life infections increase the risk of asthma and adverse lung function
-
Caregiver burden and impact of having a child with perennial allergic rhinitis: A cross-sectional study in Canada, Denmark, and the UK
-
Carry-over effect of 300 IR house dust mite sublingual immunotherapy tablet and relationship with disease activity: a post hoc analysis
-
Characterization of the CCDs from Jun o 1 and Cup a 1: advances in understanding their role in allergenicity and allergenic activity
-
Chronic inducible urticaria: classification and prominent features of physical and non-physical types
-
Clinical and Allergological Profile of Children and Adolescents With Ocular Allergy In Brazil
-
Clinical and histological differences between choanal polyps in children and adults: analysis of a 15-year series of patients treated at our institution
-
Clinical and immunological comparison between two subcutaneous immunotherapy products in children with allergic rhinitis
-
Clinical manifestations and cross-reactions with cockroaches of Formosan subterranean termite (Coptotermes formosanus) and Asian subterrabea termite (Coptotermes gestroi)
-
Clinically relevant pollen in the air: how far and high can they fly? Evidence from the German Alps and airplane flights
-
Comparing intrinsic sensitizing capacity of cow’s milk allergens β-lactoglobulin and αs-casein with hen’s egg allergen ovalbumin in an in vitro co-culture model using human epithelial and dendritic cells
-
Comparison of the efficacy of subcutaneous and sublingual immunotherapy for the treatment of allergic asthma in children
-
Complex Systems Theory and Disease: Multidisciplinary Insights and Advanced Analytics.
-
Coordinated specific IgG2 and IgE responses are associated with high clinical benefit of allergen immunotherapy with 300 IR house dust mite sublingual tablets in a large European cohort
-
Cross-Country Variations in NSAID Hypersensitivity: A Comparative Study of Clinical Presentations and Phenotypes in Spain and Turkey
-
Cross-Country Variations in NSAID Hypersensitivity: A Comparative Study of Clinical Presentations and Phenotypes in Spain and Turkey
-
Current Transition Perspectives and Practice Of Adolescents And Young Adults With Allergy And/or Asthma: A European Survey in 2023
-
Cytometric detection of Der p 1 and Der p 2 binding to Basophils (CytoBas) enables precise determination of house dust mite sensitization in patients with asthma and allergic rhinitis
-
Cytometric detection of Der p 1 and Der p 2 binding to Basophils (CytoBas) enables precise determination of house dust mite sensitization in patients with asthma and allergic rhinitis
-
Cytometry Cluster Annotation and Differential Abundance Suite (CyCadas): interactive and reproducible analysis of cytometry data
-
Cytometry Cluster Annotation and Differential Abundance Suite (CyCadas): interactive and reproducible analysis of cytometry data
-
DRAGO Application: Implementing Adherence and to House Dust Mite Allergen Immunotherapy
-
Decipher the effects of type 2-cytokines- and IL-22-induced epithelial barrier dysfunction and skin Inflammation in ex-vivo human skin
-
Decipher the effects of type 2-cytokines- and IL-22-induced epithelial barrier dysfunction and skin Inflammation in ex-vivo human skin
-
Deciphering the underlying mechanisms of NSAIDs-hypersensitivity: current knowledge and future perspectives
-
Decision points and low levels of Specific IgE – what does it actually mean for me and my patients?
-
Desensitization to Darratumumab and mastocyte cytoreduction in patient with systemic mastocytosis Smouldering and Multiple Myeloma
-
Detection of major indoor and food aeroallergens and airborne endotoxin by a novel ambient air sampling device
-
Detoxification using a specialized diet results in immunomodulatory, anti-inflammatory and antioxidant effects in patients with COVID 19 and various malignancies
-
Development and Evaluation of Algorithmic and GAN-Based Approaches for Synthetic Data Generation in Allergology
-
Development and implementation of an intelligence platform for management of allergen immunotherapy in China
-
Development of caninized anti-PD1 and anti-PD-L1 mAbs with canine constant regions IgG1 and IgG4 for cancer therapy
-
Development, characterization and application of aptamers for the detection and quantification of the major peanut allergen Ara h 1
-
Differences in sleep and quality of life in intermittent allergic rhinitis in and off-season
-
Differential effects of IgG4 vs IgE in birch allergy: blocking activity, receptor specificity and selective tropism of IgE-Bet v1 vs IgG4 immune complexes to B cells and monocytes
-
Digital twins – What can we learn and improve patient care in allergy and immunology
-
Disease burden and medication use in children with symptomatic, perennial allergic rhinitis in Canada, Denmark, and the UK: a cross-sectional survey
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) caused by bortezomib and trimethoprim/sulfamethoxazole
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Drug reaction with eosinophilia and systemic symptoms (DRESS): clinical manifestations and prognostic factors associated with disease severity
-
Dual monoclonal antibody therapy in a patient with chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma: a case report and proteome analysis
-
Dupilumab Improves Urticaria Activity, Health-Related Quality of Life, and Disease Perception and Severity in Patients with CSU: Results From the LIBERTY-CSU CUPID A Study
-
Dupilumab Reduces FeNO levels and Exacerbations and Improves Asthma Control with Inhaled Corticosteroid Withdrawal: a Phase 2 Study
-
Dupilumab-induced skin reaction in a patient with severe asthma and chronic rhinosinusitis with nasal polyposis and without prior skin conditions
-
EAACI & APAAACI Joint Symposium : Allergic and immunological diseases in Asia: current concepts and innovations : from trained immunity, microbiome and ECRS
-
Early events in infancy and the development of asthma, allergy and tolerance
-
Early immunotherapy with aeroallergens and impact on future allergy
-
Effect of 300 IR house dust mite sublingual immunotherapy tablet in paediatric patients and relationship with disease activity
-
Effect of acetylsalicylic acid on basophil activation and eicosanoid secretion in non-food allergic subjects and patients with food anaphylaxis
-
Efficacy and Safety of Dupilumab in Children Aged 6 Months to 5 Years With Atopic Dermatitis With and Without Type 2 Comorbidities
-
Efficacy and Safety of Hymenoptera Venom Immunotherapy
-
Efficacy and safety of HDM-specific subcutaneous immunotherapy on atopic dermatitis
-
Efficacy and safety of Omalizumab in a Patient, previously undergoing liver transplantation, with facial angioedema, unresponsive to corticosteroids and antihistamines
-
Egg allergen-specific T cell and cytokine responses in healthy and egg allergic children tolerating baked egg
-
Elicitors and phenotypes of tree nut-induced anaphylaxis in children and adults – data from the Anaphylaxis Registry
-
Emerging insights into food allergy mechanisms and clinical management
-
Environment and Microbial Signatures in early life, Inflammation and Allergies
-
Environmental allergy and climate change and One Health
-
Evaluation of Patients with Venom Immunotherapy Indication When Immunotherapy Preparation Could Not Be Obtained
-
Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP
-
Ex-vivo fecal fermentation model demonstrates bifidogenic effect and beneficial metabolomic shift in response to two human milk oligosaccharides and lactose in infants with cow’s milk allergy
-
Exploring Macrophage Responses in Systemic Sclerosis: Experimental Insights and Therapeutic Potential of Vitamin D3 and Alpha-Tocopherol Acetate
-
First clinical practice of using biologic therapy with dupilumab in combination with allergen-specific immunotherapy in a patient with severe atopic dermatitis and bronchial asthma
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
Food oral immunotherapy monitoring with OITcontrol® is related to reduced number of home adverse reactions and better treatment compliance compared with paper-based monitoring
-
Fractional exhaled nitric oxide levels and associations with asthma, airway symptoms and lung function – a sub-study of the Swedish CArdioPulmonary bioImage Study cohort
-
Frequency and severity of allergic reactions to non-mandatory labelled food allergens – a data analysis from the Anaphylaxis Registry and the EuroPrevall outpatient clinic study
-
GSK – Evolving understanding of IL-5: pleiotropic effects and clinical relevance in asthma and CRSwNP
-
Generation and characterization of glutaraldehyde-modified recombinant Bet v 1 and its effect on innate immune cells
-
Global Stage Session 3 – Successes and challenges of Immunotherapy
-
Grass juice-induced contact and respiratory symptoms associate with cross-reactivity to plant foods and herbs, a novel entity
-
H2020 Imptox- an assessment of consumer perceptions and attitudes towards micro- and nano-plastics (MNPs) in the role of the health effects of MNPs
-
House dust mite and staphylococcal enterotoxin B trigger heterogeneous IL-9 production by circulating skin-tropic and non-tropic memory T cells in patients with atopic dermatitis
-
House dust mite and staphylococcal enterotoxin B trigger heterogeneous IL-9 production by circulating skin-tropic and non-tropic memory T cells in patients with atopic dermatitis
-
Hymenoptera venom immunotherapy with 210 minutes Ultra-Rush protocol: patient profile and potential risk factors for systemic reactions
-
Hypersensitivity Reactions to Oxaliplatin and Carboplatin: Clinical Features and Cross Reactivity
-
ILIT.NU: Intralymphatic immunotherapy and placebo affected cSMS similarly in grass pollen allergic individuals in a large clinical trial
-
ISMA : News and views on plant and animal food allergens
-
ISMA-RHINA Joint Session : Birch pollen lessons in mechanisms and treatments of allergy
-
IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
-
IgG-Epitope Mapping of Birch-Pollen Bet v 1 Allergen in Allergic and Treated Patients for the Design of Hypoallergenic Immunotherapy Allergens
-
Immune mechanisms associated with host-microbiome interactions in health and disease
-
Immune mechanisms of food immunotherapy
-
Immunologic profile and safety of milk oral immunotherapy in children with severe cow’s milk allergy – a series of cases
-
Immunotherapy with Vespa velutina nigrithorax venom: safety of ultra-rush protocol and preliminary clinical results
-
Immunotherapy with Vespa velutina nigrithorax venom: safety of ultra-rush protocol and preliminary clinical results
-
Impact of mepolizumab on exacerbations and maintenance OCS use in patients with asthma and baseline blood eosinophil counts of ≥150–<300 cells/μL in the REALITI-A study: 2-year outcomes
-
In vitro and ex vivo assessment of the immunogenicity and safety of a depigmented-polymerized extract from Juniperus ashei
-
In-depth serum and saliva proteomic analysis of food protein-induced enterocolitis syndrome reveals dynamics of neutrophil degradation response and extracellular trap formation
-
Increase in maximum tolerated dose and decrease in symptom severity during food challenge in a clinical trial of oral immunotherapy for peanut allergy in children aged 1 to 3 years
-
Infant Diet and allergy prevention: Food allergens and beyond
-
Infant atopic dermatitis and maternal anxiety and depression: a mixed methods case-control study
-
Initial study monitoring and identifying environmental pollen and fungal spores in Samborondon, Ecuador
-
Innovation in drug allergy education: partnerships and potential across the Asia Pacific and beyond
-
Interim safety review of PVX108 peptide immunotherapy in an ongoing Phase 2 trial in peanut-allergic adolescents and children
-
Intralymphatic immunotherapy of allergic rhinoconjunctivitis with grass allergoid microcrystalline tyrosine adsorbate produced reduced medication use and symptoms: a double-blind placebo-controlled trial
-
Investigating mitochondrial metabolism dysfunction in systemic lupus erythematosus (SLE) NK cells and exploring therapeutic approaches with Hydroxychloroquine and Urolithin-A
-
Investigation of miR BART13 and BART-15 in patients with reactive arthritis induced by Chlamydia trachomatis and Epstein-Barr
-
Investigation of the predictors of asthma phenotypes (atopic and non-atopic asthma) using machine learning and traditional statistical techniques
-
Ionis Pharmaceuticals – Attack-Free in HAE? Improving Disease Control and Quality of Life With New and Emerging Long-term Prophylactic Therapies – Provided by Clinical Care Options
-
Is it possible to use the platelet and neutrophil lymphocyte ratios and systemic immune inflammation index as potential biomarkers for chronic urticaria?
-
Long-Term Efficacy and Safety of Remibrutinib in Patients with Chronic Spontaneous Urticaria in the Phase 3 REMIX-1 and REMIX-2 Studies
-
Long-Term, Real-World Effectiveness of Allergen Immunotherapy in Reducing Infectious Events in Allergic Rhinitis Patients with and without Asthma
-
Lung Function Improvement is Associated With Better Asthma Control in Adolescents and Adults Aged 12 Years and Older With Moderate-to-Severe Type 2 Asthma: A Post Hoc Analysis of QUEST
-
Maternal Diet and allergy prevention: The importance of the prenatal and early post-natal diet
-
Measurement of eosinophilic and neutrophilic granule proteins and IgE antibodies in nasal mucosal lining fluid in allergic rhinitis – A pilot study
-
Measurement of eosinophilic and neutrophilic granule proteins and IgE antibodies in nasal mucosal lining fluid in allergic rhinitis – A pilot study
-
Mechanisms and consequences of Jak-STAT signaling in the immune system
-
Mechanisms and management of hypersensitivity induced by specific drugs
-
Mechanisms of sensitization to seafood: Current knowledge and future perspectives
-
Metabolism and immunity in dendritic cells and macrophages
-
Migraine-like headache and quality of life in hereditary angioedema due to C1-inhibitor deficiency: first evidence from the Italian Network for Hereditary and Acquired Angioedema (ITACA)
-
Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure
-
Missense variant KIT p.D816V suggestive of mast cell disorder predisposes to Hymenoptera venom immunotherapy treatment complications and failure
-
Modulation of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab, assessed by nasal cytology and biopsy histology
-
Modulation of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab, assessed by nasal cytology and biopsy histology
-
Mucosal vaccine MV130 impairs eosinophilic allergic airway inflammation by restoring local and systemic healthy innate and adaptive immune responses
-
National trends in the prevalence and recurrence of anaphylaxis across all ages: The role of neighborhood deprivation and comorbidity (2002-2019)
-
Navigating Oral Food and Drug Provocation Tests: Assessing Tolerance and Safety in Clinical Settings
-
Neutrophil diversity and the regulation of innate and adaptive immunity
-
Neutrophil response mechanisms in allergy and immunity
-
Neutrophils in allergy and inflammation: update and emerging roles
-
New directions in immunotherapy and vaccinology
-
Novel analytical tool supporting drug development and biomarker discovery: The era of machine learning in Allergy and Immunology
-
Novel mechanisms and insights on anaphylaxis
-
One-dilution rapid desensitization protocol to chemotherapeutic and biological agents: patient profile, protocol and tolerability
-
One-dilution rapid desensitization protocol to chemotherapeutic and biological agents: patient profile, protocol and tolerability
-
Oral Immunotherapy with omalizumab in an adult patient with severe milk and egg allergy
-
Oral immunotherapy (OIT) in walnut and hazelnut co-allergic patients: ELISA inhibition studies to direct treatment approach
-
Patients undergoing immunotherapy with Alternaria alternata: prevalence of asthma and co-sensitization to other allergens
-
Pediatric patients undergoing immunotherapy with alternaria alternata: demographic and clinical characterization
-
Peripheral blood and urine metabolites associated with NERD after ASA challenge and long-term ASA therapy
-
Peripheral blood and urine metabolites associated with NERD after ASA challenge and long-term ASA therapy
-
Persistence and Diversity in Allergen-Specific B-Cell Memory: Lessons from Long-term Beekeepers, Novice Beekeepers, and VIT-treated Allergic Patients
-
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Stapokibart in Healthy and Atopic Dermatitis Adult Subjects
-
Positive outcome of the pivotal Phase III study with PQ Grass, a modified grass allergen subcutaneous immunotherapy (SCIT) product using MicroCrystalline Tyrosine and Monophosphoryl Lipid A as adjuvant system
-
Potential cross-reactivity between a clover and grass protein blend and allergens from legumes or grass pollen
-
Predicting the Efficacy of Allergen Immunotherapy in Asthma Based on Initial-Year Outcome: Insights from the Estimated Daily Symptom and Medication Score
-
Prevalence and causes of AR and asthma in Mongolia
-
Prevalence of Severe Atopic Dermatitis and Comorbid Chronic Systemic Diseases is Increasing in Korean Children and Adolescents
-
Prevalence of allergic sensitization to Quercus ilex and its clinical relevance in pollen food allergy syndrome. Differences between pediatric and adult populations
-
Pro-inflammatory cytokines (IL-6 and TNF), influence of the JAK-STAT cascade and negative regulation of the Hyppo pathway in the severe asthma phenotype
-
Putting everything together and and future learning opportunities
-
Pyogenic Arthritis, Pyoderma Gangrenosum and Acne (PAPA) and PAPA-Like Syndromes: Systematic Review of The Literature
-
Respiratory Allergies and Sensitization Patterns to Pollen in European and Sub-Saharan African Patients with Atopic Dermatitis
-
Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes
-
Safety and Tolerability of Rush Updosing Using a Mugwort Allergoid Extract for Subcutaneous Allergen Immunotherapy
-
Safety and efficacy of dietary advancement therapies: a systematic review and meta-analysis
-
Safety and tolerance response of a two day rush protocol treatment in immunotherapy using purified Apis mellifera dry Honeybee venom extract
-
Safety of oral immunotherapy in preschool aged children with single and multiple food allergy (the ORKA trial): a prospective intervention study
-
Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Briquilimab after Single Subcutaneous (SC) Administration to Healthy Male and Female Participants
-
Serial fractional exhaled nitric oxide measurements at and off work: usefulness for diagnosis and tertiary prevention of occupational asthma
-
Serum cytokine profiles of pediatric normal weight asthma and overweight/obese asthma and their correlation with pulmonary function indices
-
Single-center prospective interventional study in patients with walnut allergy or sensitization and its relationship with macadamia and Brasil nut allergy
-
Specific IgE and IgG4 changes in adults undergoing peanut immunotherapy combined with omalizumab
-
Storage proteins: clinical and molecular patterns of peanut and tree nut allergy of a pediatric portuguese population
-
Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions
-
Subcutaneous short-course grass AIT: molecular mechanisms of humoral immune tolerance and translation into clinical efficacy
-
Subcutaneous short-course grass AIT: molecular mechanisms of humoral immune tolerance and translation into clinical efficacy
-
Sublingual immunotherapy for house dust mite allergy induces expansions of allergen-specific memory B cells expressing CD29 and downregulating IL4Rα
-
Successes and challenges of Immunotherapy
-
Successes and challenges of Immunotherapy
-
Successes and challenges of Immunotherapy
-
Successful immunotherapy with cow’s milk and omalizumab in a 24-year-old patient with extreme cow’s milk allergy
-
Systematic literature review and adjusted indirect treatment comparisons of 2 allergen immunotherapy treatments for grass pollen–induced allergic rhinitis
-
The HMOS 2’FL and 3FL prevent house dust mite induced proinflammatory cytokine release in vitro and decrease HDM-specific IgE in an allergic asthma murine model
-
The SQ HDM SLIT-tablet is effective and well-tolerated in children (5-11 years) with house dust mite allergic rhinitis/rhinoconjunctivitis with and without concomitant asthma – results from a global phase III clinical trial
-
The epicutaneous immunotherapy for peanut allergy: most recent results and perspectives
-
The importance of the storage proteins for allergenicity and molecular patterns of cross-reactvity in a peanut and tree nut allergic pediatric population
-
The influence of environmental factors on pregnancy and perinatal outcomes in patients with and without respiratory allergy: a retrospective study
-
The influence respiratory allergy, air pollutants and obesity on obstetrics and perinatal outcomes
-
The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood
-
The interaction of atopy and reduced biodiversity of upper airway microbiome promotes higher nasal expression of IL-5 and asthma persistence in early childhood
-
The role of differential expression of HR1 and HR2 on B cells and their functions
-
The sensitization profile in children with perennial and seasonal allergic rhinitis in Kyiv and Kyiv region
-
The utility of basophil activation testing in honey bee venom allergy diagnosis and venom immunotherapy
-
Theoretical and practical translational medicine approaches for primary and secondary prevention of food allergy
-
Trained innate immunity and immunotherapy
-
Treatment satisfaction and health literacy among patients undergoing allergen-specific immunotherapy -Data from a tertiary allergy centre
-
Triggers and Mechanisms of Asthma Exacerbations: One Outcome, Many Paths?
-
Use of the AllergyVax Doctor app to evaluate the correlation between adherence to treatment and control of rhinitis and asthma in patients during treatment with SLIT
-
Variability in the genes involved in the cellular redox status, and their association with drug hypersensitivity reactions to nonsteroidal anti-inflammatory drugs and ß-lactam antibiotics
-
Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life
-
Venom Allergen Immunotherapy in Children: Efficacy, Persistence of Efficacy and Impact on Quality of Life
-
What is asthma remission and what can we learn from other autoimmune and inflammatory disease about remission?
-
Worldwide experiences and unmet needs of patients with chronic spontaneous urticaria and treating physicians: The Urticaria Voices study
-
Сytokine profiles in patients with allergic rhinitis during allergen-specific immunotherapy with and without added vitamin D
-
Adherence to a sustainable and healthy dietary pattern and its impact on asthma and airway inflammation
-
Adherence to a sustainable and healthy dietary pattern and its impact on asthma and airway inflammation
-
Age and sex as determinants of total and specific Immunoglobulin E in the middle-aged and elderly population
-
Anaphylaxis from shellfish and mollusks and cross-reactive allergies: the impact of ‘novel foods’ containing insect flours on sensitization and allergic risk in childre
-
B Cell Repertoires and Phenotypes in Food Allergy and Oral Immunotherapy
-
COPD and asthma: longitudinal and cross-sectoral real-world data for machine learning application for quality improvement and knowledge acquisition – CALM-QE
-
Designing Modified Variants of Ara h 1 and Ara h 2 for Safe and Effective Immunotherapy
-
Efficacy and safety of sublingual immunotherapy for mite in children and adolescents with AR
-
Eosinophilic esophagitis in children and adolescents: clinical, endoscopic, histologic findings, and response to treatment with: fluticasone, budesonide, proton inhibitors and dupilumab
-
Evaluation of the efficacy, adverse effects, and cost-effectiveness of sublingual immunotherapy with dominant allergens for allergic rhinitis due to respiratory allergens in adults and children
-
House dust mite sublingual immunotherapy comprehensively improves asthma and allergic rhinitis in children and adolescents
-
In vitro safety profile and tolerogenic response with depigmented and polymerized extracts in polyallergic patients to grass pollen and cat epithelia
-
Inflammatory and Oxidative Stress Markers in Serum, Urine and Exhaled Breath Condensate: Relationship between Asthma and Obesity in Children
-
Interpreting epidemiologic distribution of total and specific IgE levels for food allergy in Southern China from 2004 to 2023: understanding the mechanisms and focusing on prevention
-
Mechanisms and Predictors of Response or Failure to Biologic Therapies in Asthma and Allergy
-
Mucosal delivery of allergen-specific immunotherapy with vaccine adjuvants suppresses allergic disease through both humoral and cellular immune mechanisms
-
One-strength dose escalation using a birch pollen allergoid for subcutaneous immunotherapy is safe and well-tolerated in children, adolescents and adults
-
Preconception paternal and maternal smoking alters gene expression in the early murine embryo and aggravates AHR and eosinophilia in adult offspring
-
Relationship between mode of delivery and allergic diseases, total serum IgE and fractional exhaled nitric oxide and among Taiwanese children
-
Relationship between mode of delivery and allergic diseases, total serum IgE and fractional exhaled nitric oxide and among Taiwanese children
-
Safety and tolerability of in-season initiation of subcutaneous and sublingual allergen immunotherapy with SQ grass pollen products: a comprehensive review
-
Safety of a cluster strategy, effectiveness and immunological changes in allergic children sensitized to house dust mites with native and modified subcutaneous immunotherapy treatment
-
Stallergenes Greer – “Allergen Harmony”: New data for a tailored and sustained food and respiratory immunotherapy effect
-
Successes and challenges of Immunotherapy in Poland and EU
-
The increased respiratory effort during sleep is related to inflammation which burst stress mechanisms inducing food protein induced enterocolitis (FPIES), eczema, asthma, and metabolic disorders in children and adolescents
-
Turkish National Hereditary Angioedema and Acquired Angioedema Registry, Established to Encourage Standardizing the Care and Management of the Disease. HAE/AAE-TR National Hereditary and Acquired Angioedema Registry Group
-
Venom Immunotherapy in children and adolescents: safety and outcome in a study group from a third level Italian center
-
A dose ranging study of sting challenge and specific lgE, IgG4, venom skin test and basophil activation responses to ant venom immunotherapy with and without delta-inulin adjuvant
Show more Sessions (247)Show Less-
-
Annual Congress 2023 of the European Academy of Allergy and Clinical Immunology: Study Shows Promising Results for Immunotherapy Targeting Skin Cancer
-
No collaboration and partnership between EAACI and GA2LEN. No joint guideline(s)
-
EAACI’s Research and Outreach Committee (ROC): Advancing Allergy, Asthma, and Clinical Immunology Research and Care
Show more News (1)Show Less-